Results 141 to 150 of about 29,994,236 (203)

Traditional Medicine Extracts of <i>Gnidia sericocephala</i> and Product Nkabinde in HIV-1 Latency Reversal: Insights from J-Lat Subtype B and J-Lat Subtype C Models. [PDF]

Int J Mol Sci
Mngomezulu K, Khathi SP, Nkabinde SA, Nkabinde M, Ngcobo M, Gqaleni N.   +5 more
europepmc   +1 more source

HIV-1 latency reversal and immune enhancing activity of IL-15 is not influenced by sex hormones. [PDF]

JCI Insight
Holmberg CS, Levinger C, Abongwa M, Ceriani C, Archin NM, Siegel M, Ghosh M, Bosque A.   +7 more
europepmc   +1 more source

<i>Ex vivo</i> and <i>in vivo</i> HIV-1 latency reversal by "Mukungulu," a protein kinase C-activating African medicinal plant extract. [PDF]

mBio
Richard K, Yuan Z, Tang H-Y, Goldman AR, Kuthu R, Raphane B, Register ET, Sharma P, Ross BN, Morris J, Williams DE, Cheney C, Wu G, Mounzer K, Laird GM, Zuck P, Andersen RJ, Simonambango S, Andrae-Marobela K, Tietjen I, Montaner LJ.   +20 more
europepmc   +1 more source

Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal. [PDF]

Antimicrob Agents Chemother, 2018
Spivak AM, Nell RA, Petersen M, Martins L, Sebahar P, Looper RE, Planelles V.   +6 more
europepmc   +1 more source

Pan-caspase inhibitors induce secretion of HIV-1 latency reversal agent lymphotoxin-alpha from cytokine-primed NK cells. [PDF]

Cell Death Discov
Hajikhezri Z, Zygouras I, Sönnerborg A, van Domselaar R.   +3 more
europepmc   +1 more source

Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4⁺ T cell activation and HIV-1 latency reversal. [PDF]

Sci Adv, 2019
Cao S, Slack SD, Levy CN, Hughes SM, Jiang Y, Yogodzinski C, Roychoudhury P, Jerome KR, Schiffer JT, Hladik F, Woodrow KA.   +10 more
europepmc   +1 more source

Dendritic cells as natural latency reversing agent: A wake-up call for HIV-1 [PDF]

Virulence, 2017
van Montfort, T., Speijer, D., Berkhout, B.   +2 more
openaire   +2 more sources

Integration site-independent enhancement of latency reversal by HIV-1 Nef

Journal of Virus Eradication, 2017
X.T. Kuang, S.W. Jin, T.M. Markle, M.A. Brockman   +3 more
openaire   +2 more sources

Novel use of alprazolam as a potential HIV-1 latency reversing agent

Journal of Virus Eradication, 2017
W. Elbezanti, A. Lin, S. Luca, F. Maldarelli, Z. Klase   +4 more
openaire   +2 more sources

HIV_GKO: A Tool to Assess HIV-1 Latency Reversal Agents in Human Primary CD4⁺ T Cells. [PDF]

Bio Protoc, 2018
Battivelli E, Verdin E.
europepmc   +1 more source